Y Intercept Hong Kong Ltd Has $263,000 Stake in The Cooper Companies, Inc. (NASDAQ:COO)

Y Intercept Hong Kong Ltd trimmed its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 85.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,113 shares of the medical device company's stock after selling 18,478 shares during the period. Y Intercept Hong Kong Ltd's holdings in Cooper Companies were worth $263,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. T. Rowe Price Investment Management Inc. increased its stake in Cooper Companies by 2.1% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 7,678,965 shares of the medical device company's stock valued at $705,928,000 after purchasing an additional 155,233 shares in the last quarter. Geode Capital Management LLC increased its stake in Cooper Companies by 2.3% in the fourth quarter. Geode Capital Management LLC now owns 4,906,463 shares of the medical device company's stock valued at $449,907,000 after purchasing an additional 109,907 shares in the last quarter. Price T Rowe Associates Inc. MD increased its stake in Cooper Companies by 517.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 3,529,477 shares of the medical device company's stock valued at $324,466,000 after purchasing an additional 2,957,421 shares in the last quarter. FMR LLC increased its position in shares of Cooper Companies by 97.6% during the fourth quarter. FMR LLC now owns 2,218,112 shares of the medical device company's stock worth $203,911,000 after acquiring an additional 1,095,805 shares in the last quarter. Finally, Northern Trust Corp raised its holdings in shares of Cooper Companies by 15.4% during the fourth quarter. Northern Trust Corp now owns 2,018,898 shares of the medical device company's stock worth $185,597,000 after acquiring an additional 268,972 shares during the period. 24.39% of the stock is owned by institutional investors.

Cooper Companies Price Performance

COO stock traded up $0.18 during mid-day trading on Friday, hitting $70.87. The stock had a trading volume of 1,359,138 shares, compared to its average volume of 2,286,900. The company has a current ratio of 2.10, a quick ratio of 1.23 and a debt-to-equity ratio of 0.30. The Cooper Companies, Inc. has a 52 week low of $65.00 and a 52 week high of $112.38. The firm has a market capitalization of $14.17 billion, a P/E ratio of 34.40, a P/E/G ratio of 1.72 and a beta of 1.00. The firm has a fifty day simple moving average of $72.49 and a 200 day simple moving average of $80.88.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, beating the consensus estimate of $0.93 by $0.03. The firm had revenue of $1 billion for the quarter, compared to analyst estimates of $995.12 million. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The business's quarterly revenue was up 6.3% compared to the same quarter last year. During the same period last year, the firm earned $0.85 EPS. As a group, research analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analyst Ratings Changes

COO has been the topic of a number of research analyst reports. JPMorgan Chase & Co. restated a "neutral" rating and set a $76.00 price objective (down from $110.00) on shares of Cooper Companies in a report on Friday, May 30th. Mizuho dropped their price objective on shares of Cooper Companies from $105.00 to $90.00 and set an "outperform" rating on the stock in a report on Wednesday, July 16th. UBS Group upgraded shares of Cooper Companies to a "buy" rating in a report on Tuesday, June 17th. Wall Street Zen lowered shares of Cooper Companies from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. Finally, Needham & Company LLC upgraded shares of Cooper Companies from a "hold" rating to a "buy" rating and set a $94.00 price objective on the stock in a report on Tuesday, June 17th. Three analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $96.73.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.